Table 2.
The summary of QOL study.
| Characteristics | Tolerant group (n = 5) | Conventional group (n = 32) | P value |
|---|---|---|---|
| Complications –No. of events (%) | .33 | ||
| Malignancy | 0 | 4 (11.8) | .41 |
| Infection | 2 (40.0) | 14 (43.8) | .62 |
| Medications after transplant -% patients | .002 | ||
| Hypertension | 20 | 78.1 | .004 |
| Dyslipidemia | 0 | 40.6 | .07 |
| Diabetes requiring insulin | 0 | 12.5 | .40 |
| QOL measure | Tolerant group (n = 5) | Conventional group (n = 16) | |
| Kidney transplant-targeted scales | |||
| Burden of kidney transplantation | 98.75 ± 11.27 | 70.70 ± 30.50 | .04 |
| Sexual function | 100 | 70.83 ± 33.07 | .04 |
| 36-item health survey scales | |||
| Physical function | 98.89 ± 2.48 | 73.95 ± 31.6 | .04 |
| General health | 76.00 ± 6.52 | 51.87 ± 28.33 | .04 |
| Social function | 100 | 70.31 ± 32.87 | .03 |
| Energy/fatigue | 72.00 ± 5.70 | 52.50 ± 21.21 | .04 |
| Overall health | 90.00 ± 7.07 | 66.87 ± 23.30 | .01 |
| Symptom occurrence (mean % occurrence) | Tolerant group (n = 5) | Conventional group (n = 16) | |
| Depressed | 0 | 32.14 | .001 |
| Excessive appetite | 0 | 30.36 | .006 |
| Flatulence | 0 | 17.86 | .04 |
| Healing loss | 0 | 21.43 | .04 |
| Increased thirst | 6.25 | 35.71 | .04 |
| Itching | 0 | 17.86 | .04 |
| Joint pain | 0 | 23.21 | .02 |
| Lack of energy | 12.5 | 32.14 | .04 |
| Muscle cramps | 0 | 17.86 | .02 |
| Reduced libido | 0 | 28.57 | .04 |
| Shortness of breath | 0 | 17.86 | .02 |